Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04235231
Other study ID # RHL-NICU-2020-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2021
Est. completion date December 30, 2024

Study information

Verified date December 2023
Source Regional Hospital Liberec
Contact Vera Spatenkova, MD, Ph.D.
Phone 00420 724 027 126
Email vera.spatenkova@nemlib.cz
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prevention of lung inhomogeneity is an essential part of preventive strategy in neurocritical care, reducing the risks of secondary brain damage from hypoxemia, hypo/hypercapnia or pneumonia.


Description:

In the monocentric, intervention, prospective, randomized study, the investigators will examine the effect of lateral tilting (routinely used in critical care) on the lung inhomogeneity that will be analyzed by electrical impedance tomography (EIT) in the unconscious patients with acute primary brain disease and artificial pulmonary ventilation. Two types of lateral tilting will be compared: manual positioning of body by nurse versus the bed tilting (15° lateral tilt, original company (LINET) and product brand name (Eleganza 5).


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Primary brain disease - Hospitalization in Neurocenter, Neurointensive Care Unit - Age>18 years - Unconsciousness - Artificial pulmonary ventilation Exclusion Criteria: - Intracranial hypertension - History of primary lung disease - The terminal stage of the disease - Refractory hemodynamic instability

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Bed tilting
15° lateral tilt, original product brand name LINET Eleganza 5
Other:
Body positioning
Manual positioning of body by nurse: left side, back, right side, using positioning pillows

Locations

Country Name City State
Czechia Regional Hospital Liberec Liberec

Sponsors (4)

Lead Sponsor Collaborator
Regional Hospital Liberec Charles University, Czech Republic, Technology Agency of the Czech Republic, University of Sao Paulo

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Atelectasis/collapse Assessed by electrical impedance tomography (EIT) or chest x-ray (CXR) at end of observation period up to 24 weeks
Secondary Evaluating oxygenation parameters Oxygen saturation up to 24 weeks
Secondary Evaluating hemodynamic parameters Hemodynamic monitoring: stroke volume variation (SVV) up to 24 weeks
Secondary Cost effectiveness measurement between two groups Therapeutic Intervention Scoring System (TISS) up to 24 weeks
Secondary Profiling pneumonia incidence Pneumonia score up to 24 weeks
Secondary Comparing duration of stay in Neurocenter Neurointensive Care Unit Days of hospitalization up to 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT02919267 - Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms N/A
Completed NCT04506203 - The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic Tool N/A
Completed NCT03314519 - Lung Ultrasonography vs Fiberoptic Bronchoscopy for Aiding Lung Collapse in Patient Using Double Lumen Tube N/A
Completed NCT03155711 - HFNC for Induction During Bariatric Surgery Patients. N/A
Recruiting NCT03369483 - Abdominal Pressure Assessment Following Open Abdominal Surgery
Completed NCT02798133 - Open Lung Approach Versus Standard Protective Strategies N/A
Recruiting NCT03133754 - OLA to Lowest DP in Cardiac Surgery N/A
Completed NCT03142997 - Spontaneous Ventilation Versus Controlled Ventilation on Lung Atelectasis in Children. N/A